Latest Healius News & Updates

See the latest news and media coverage for Healius. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Healius

Pathology and diagnostic services provider

healius.com.au
Headquarters
Sydney, Australia
Company type
Public company
Number of employees
5,000–10,000

Last updated

Latest news about Healius

In short: Healius Limited downgraded its earnings outlook and considered a business sale following a period of revenue growth and strategic divestments.

Company announcements

Healius

Healius announces 1H 2026 results

Group revenue rises 3.8% to $688.1M, EBITDA up 13.1% to $122.2M, EBIT $7.9M from prior loss. Pathology revenue up 3.5%, Agilex up 16%.

Healius

Healius Limited reports half-year financial results

Revenue grows 3.9% to $688.1M with underlying EBIT of $7.9M. Net loss stands at $30.4M. No dividend declared.

Unlock all announcements with a

Media coverage

The Globe and Mail

Healius Limited (PGZ) Gets a Sell from Jarden

Jarden analyst Steven Wheen maintained a Sell rating on Healius Limited yesterday and set a price target of A$0.47. The company's shares closed yesterday at...

Australian Financial Review

Pathology group Healius slashes earnings outlook, plans Agilex sale

The company's shares plunged on the profit downgrade, which it blamed on declining pathology unit volumes and lack of government funding.

Unlock all articles with a

Never miss news about Healius

Track Healius and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Healius competitors & trending companies

Browse news for competitors to Healius and other trending companies.